Deferasirox is an oral iron chelation therapy used to manage chronic iron overload associated with conditions requiring repeated blood transfusions. The drug has become an important therapeutic option for patients who require long-term management of excess iron levels. The Deferasirox Market was valued at US$ 3.14 Billion in 2025 and is projected to reach US$ 4.51 Billion by 2034,...